Session 8B: Is software eating the medical devices industry? Is there a future for non-connected medical devices?
Tracks
Track 2
| Thursday, May 21, 2026 |
| 3:40 PM - 4:25 PM |
Details
Software is no longer just an add-on to medical devices - it is increasingly the core source of value, differentiation and scale. This panel explores how connected devices, AI-enabled software and data layers are reshaping product strategy, clinical impact and commercial models across medtech. This panel brings together founders and leaders from connected Medtech and AI companies to unpack what really changes once software becomes part of the value proposition. Topics will include pricing and reimbursement, subscription versus capital models, regulatory pathways for software components, ongoing validation and maintenance, and how buyers perceive (and pay for) software compared to hardware.
Speaker
Mr Rowan Ashwin
Lead Machine Learning Engineer
OncoRes Medical
Panellist
Alex Barty
Director, Non-Dilutive Investments Programs & Portfolio
ANDHealth
Chair
John Konstantopoulos
Co-Founder and Chief Executive Officer
Artrya Ltd
Panellist
Trang Nguyen
Chief Executive Officer
SeeTreat Medical
Panellist
